CMAJ Study Reveals Alcohol Related Deaths Jump 18% During PandemicAlcohol-related deaths increased 18% during the pandemic, as did hospitalizations ...
Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...